Isolation and characterization of some potential impurities in ropinirole hydrochloride

Journal of Pharmaceutical and Biomedical Analysis

Volumn 43, Issue 4, 2007, Pages 1587-1593

  Sahasrabuddhey, B ^a   Nautiyal, R ^a   Acharya, H ^a   Khyade, S ^a   Luthra, P K ^a   Deshpande, P B ^a  

^a Alembic Limited   (India)

Author keywords

Characterization; Impurities; Isolation; Ropinirole

Indexed keywords

4 [2 (PROPYLAMINO)ETHYL] 1,3 DIHYDRO 2H INDOL 2 ONE; 5 [2 (DIPROPYLAMINOETHYL] 1,4 DIHYDRO 3H BENZOXAZIN 3 ONE; BENZOXAZINE DERIVATIVE; INDOLE DERIVATIVE; ROPINIROLE; UNCLASSIFIED DRUG;

ARTICLE; DRUG IMPURITY; DRUG ISOLATION; DRUG STRUCTURE; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STRUCTURE ANALYSIS;

ANTIPARKINSON AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CONTAMINATION; INDOLES; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MOLECULAR STRUCTURE; SPECTROPHOTOMETRY, INFRARED; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 33847127039     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.11.030     Document Type: Article

References (11)

1. Angyal S.J. Org. React. 8 (1954) 197-206
2. Bhatt J., Jangid A., Shetty R., Shah B., Kambli S., Subbaiah G., and Singh S. J. Pharm. Biomed. Anal. 40 (2006) 1202-1208
3. Coufal P., Stulik K., Claessens H.A., Hardy M.J., and Webb M. J. Chormatogr. B 732 (1999) 437-444
4. Coufal P., Stulik K., Claessens H.A., Hardy M.J., and Webb M. J. Chormatogr. B 720 (1998) 197-204
5. Swagzdis J.E., and Mico B.A. J. Pharm. Sci. 75 (1986) 90-91
6. Hacket J. J. Anal. Toxcol. 30 (2006) 44-49
7. Beatie I.G., and Blake T.J.A. J. Chormatogr. 474 (1989) 123-138
8. Bryant D.K., Kingswood M.D., and Belenguer A. J. Chromatogr. A 721 (1996) 41-51
9. McCrossen S.D., Giles R.G., Oxley P.W., and McArdle J.V. J. Chormatogr. A 623 (1992) 229-235
10. Zissis K.D., Brereton R.G., and Escott R. Analyst 122 (1997) 1007-1013
11. ICH Guideline Q3A (R), Impurities in New Drug Substances, 7 February, 2002.